Clinical Trial Update: A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of adalimumab in pediatric subjects with Enthesitis Related Arthritis has completed, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enthesitis-related Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Enthesitis Related Arthritis (ERA) | Phase 3 | Status: COMPLETED | Results posted: 2016-06-21